Healthcare organizations are confronting an overwhelming number of AI vendors lately. Most products appear similar in presentations and slide decks, making it difficult for buyers to differentiate between product A and B. The real challenge — more than finding AI solutions — is building a selection process that scales as vendor volume increases.
The fastest path to a good AI decision is an intentional, structured evaluation process. Here are three things every healthcare executive should know before choosing a vendor.
1. Strategic Alignment Matters More Than Product Features
Organizations should determine whether any AI solution fits its strategic priorities before investing in detailed vendor comparisons. Vendor evaluations often begin with feature matrices and procurement exercises. They should begin with questions of strategic fit.
Before asking whether the technology works, ask whether it advances a priority the organization has already committed to pursuing. Therein lies the answer to the question of whether Product A is better than Product B. Even at this early stage, alignment among an organization’s stakeholders is critical. That starts at the top.
Executive sponsorship is not a formality; someone must be accountable for outcomes, adoption, and integration. If no senior leader is willing to own the implementation and consequences of a deployment, the evaluation should stop. Accountability and strategic alignment should be established before deeper analysis begins.
2. Risk Assessment Should Run Alongside Value Assessment — Not After It
Organizations should evaluate potential impact and potential risk simultaneously. The strongest evaluation frameworks treat impact and risk as parallel workstreams. High-value use cases do not earn a pass on risk scrutiny.
Not all risks are equal, of course. Enterprise risk, clinical documentation and decision support, and quality and patient safety deserve the greatest weight. The consequences of AI failure extend beyond a single deployment, affecting trust, adoption, operations, and future AI initiatives.
Vendors should be able to explain how they identify safety risks and manage incidents before deployment. A promising ROI projection is not enough; the organizations adopting AI tools the fastest are those doing the hardest risk analysis earliest.
3. Maturity Beats Cost
The most sophisticated healthcare buyers prioritize readiness, reliability, and proven outcomes over purchase price. The upfront cost matters, but leading healthcare organizations increasingly place greater emphasis on technology maturity, patient-care risk, and near-term value.
The true cost of an immature solution includes operational disruption, safety concerns, reputational damage, and implementation failure — the kind of sticker shock that is harder to predict, and comes due when you don’t expect it.
Vendors that can demonstrate measurable impact deserve attention, while vendors that rely on claims without evidence should be treated cautiously. Beware of buying cheaply. A lower-priced vendor is not necessarily the lower-cost choice when failure carries organizational consequences.
Choose Slow, Buy Fast
AI vendor selection should not depend on demos, enthusiasm, or intuition. A repeatable framework creates defensible decisions that can scale across dozens of vendor evaluations.
Organizations that slow down to establish strategic alignment, evaluate risk rigorously, and prioritize maturity are ultimately able to move faster when it is time to buy. A process capable of identifying the right vendors in a crowded field is a competitive advantage in today’s environment. Organizations that slow down to establish strategic alignment, evaluate risk rigorously, and prioritize maturity are ultimately able to move faster when it is time to buy.
About Zach Evans
Zach Evans is the Chief Technology Officer with Xsolis, the AI-driven health technology company with a human-centered approach, where he is responsible for using Xsolis’ proprietary real-time predictive analytics and technology to support client objectives and internal business operations.
